CIK 0001196298
- Non-accelerated filer
- Smaller reporting company
NEPHROS INC
Sign in to watch- Ticker
- NEPH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133971809
- Phone
- +1 201-343-5202
- Business address
- 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
- 4 Grant or award Director acquired 42,481 shares (grant or award)
- 4 Grant or award Director acquired 27,613 shares (grant or award)
- 4 Grant or award Director acquired 27,613 shares (grant or award)
- 4 Grant or award Director acquired 8,402 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion President, CEO & CFO acquired 14,815 shares (option exercise)
- 4 Shares withheld for taxes Chief Marketing Officer gave up 6,389 shares (to pay taxes)
- 4 Grant or award Director acquired 4,582 shares (grant or award)
- 4 Grant or award Director acquired 4,582 shares (grant or award)
- 4 Grant or award Director acquired 5,429 shares (grant or award)
- 4 Grant or award Director acquired 4,582 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Marketing Officer bought 1,000 shares at $7.92 ($7,920)
- 4 Open-market buy Director bought 5,000 shares at $7.64 ($38,200)
- 4 Open-market buy President & CEO bought 5,000 shares at an average $7.72 ($38,605)
- 4 Option exercise Director acquired 66,667 shares (option exercise)
- 4/A Shares withheld for taxes CEO Specialty Renal Products gave up 698 shares (to pay taxes)
- 4 Option exercise CEO of Specialty Renal Product acquired 2,222 shares (option exercise)
Page 3 of 17 · 332 filings